Executive Director, Medical Writing
Quick Summary
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values,
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Nice to Have
~4 min readThe Executive Director, Medical Writing serves as the functional lead for Medical Writing, providing strategic and operational leadership across the full product lifecycle. This role is responsible for establishing the vision, operating model, and capabilities of the Medical Writing function while ensuring the delivery of high-quality, scientifically rigorous, and submission-ready documentation that supports Kyverna's development, regulatory, and commercialization objectives.
As a key member of the Regulatory leadership team, the Executive Director partners closely with Regulatory Affairs, Clinical Development, Clinical Operations, Biometrics, Medical Affairs, Pharmacovigilance, Quality, and Program Leadership to translate portfolio priorities into effective medical writing strategies and execution plans. This individual influences functional and portfolio decisions through operational expertise, identifies and mitigates regulatory documentation risks, and builds organizational capabilities that enable successful global submissions and lifecycle management.
The national salary range for this position is $275K to $300K USD annually. The salary range is an estimate of what we reasonably expect to pay for this position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock plan.
Location & Eligibility
Listing Details
- Posted
- August 11, 2026
- First seen
- August 11, 2026
- Last seen
- August 12, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 68%
- Scored at
- August 11, 2026
Signal breakdown

Kyverna Therapeutics is a biopharmaceutical company focused on developing innovative CAR T-cell therapies for autoimmune diseases.
View company profilePlease let Kyverna know you found this job on Jobera.
3 other jobs at Kyverna
View all →Explore open roles at Kyverna.
Similar Director jobs
View all →Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.